12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients

NCT00616733 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: CS-0777 tablets
DRUG: CS-0777 tablets
DRUG: CS-0777 tablets

Sponsor

Daiichi Sankyo